AdaptHealth Corp.
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
During the three months ended June 30, 2026, none of the Company's directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933).
The information set forth in is included for the purpose of providing disclosure under “Item 2.03 — Creation of a Direct Financial Obligation” of Form 8-K.
On July 27, 2026, the Company borrowed $325.0 million under the 2026 Delayed Draw Term Loan and the 2026 Credit Agreement to pay the redemption price of the 6.125% Senior Notes. Such notes were redeemed on August 3, 2026. The 2026 Delayed Draw Term Loan matures in April 2031. We will make quarterly or monthly interest payments depending on the interest period and principal payments in accordance with the terms of the 2026 Credit Agreement. The 2026 Credit Agreement contains customary representations, warranties, covenants and events of default. The forgoing summary description of the 2026 Delayed Draw Term Loan and the 2026 Credit Agreement is not complete and is qualified by the text of the 2026 Credit Agreement, which is attached as Exhibit 10.1 of the Company’s Current Report on Form 8-K, filed with the SEC on April 13, 2026 and is incorporated by reference herein.
See Note 12, Debt, included in the accompanying notes to the interim consolidated financial statements for the three and six months ended June 30, 2026 and 2025 and Liquidity and Capital Resources section of this Quarterly Report for additional discussion.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.